Citation data

OpenCitations

Works that cite this article, indexed by OpenCitations.

5 resultsUpdated October 20, 2026
1

A randomised Phase II trial of carboplatin and gemcitabine ± vandetanib in first‐line treatment of patients with advanced urothelial cell cancer not suitable to receive cisplatin

BJU International 126(2) (2020)

Robert Jones; Simon Crabb; John Chester; Tony Elliott; Robert Huddart; Alison Birtle; Linda Evans; Jason Lester; Satinder Jagdev; Angela Casbard; Chao Huang; Tracie‐Ann Madden; Gareth Griffiths

2

Relationship between EGFR expression and subcellular localization with cancer development and clinical outcome

Oncotarget 10(20) (2019)

Ge Yan; Mohamed E.M. Saeed; Sebastian Foersch; Jose Schneider; Wilfried Roth; Thomas Efferth

3

Follicular dendritic cell sarcoma (FDCS) of urinary bladder with coexisting urothelial carcinoma–a case report

BMC Urology 19(1) (2019)

Jing Sun; Cheng Wang; Dandan Wang; Jiangtao Wu; Leiming Wang; Lan Zhao; Lianghong Teng

4

EGFR EXPRESSION IN PRIMARY EPITHELIAL URINARY BLADDER TUMORS AND ITS CORRELATION WITH CLINICOPATHOLOGICAL PARAMETERS

INDIAN JOURNAL OF APPLIED RESEARCH (2021)

Deepika Sharma; Sudarshan Kumar Sharma; Pamposh Raina; Anchana Gulati

5

Prevalence of the Vascular Endothelial Growth Factor Receptor (VEGER) in Transitional Cell Carcinoma (TCC) of Bladder and its Relationship with Other Prognostic Factors

International Journal of Cancer Management In Press(In Press) (2018)

Hamidreza Mirzaei; Parisa Sabetrasekh; Parto Sabetrasekh; Mahmoud Parvin; Peyman Torbati; Parastoo Hajian